BTIG Reiterates Buy on AtriCure, Maintains $54 Price Target

AtriCure, Inc. -0.10%

AtriCure, Inc.

ATRC

29.37

-0.10%

BTIG analyst Marie Thibault reiterates AtriCure (NASDAQ: ATRC) with a Buy and maintains $54 price target.